Disease Interception and the US National Cancer Moonshot

April 26, 2016

Develop. Innovate. Advance. DIA is the only global organization dedicated to bringing health care product development professionals together in a neutral environment to improve health and well-being throughout the world. - See more at:http://www.diaglobal.org/en/about-us#sthash.uT0zazfD.dpuf

April 26, 2016.

In the US, patients, caregivers and advocates, drug developers and the FDA have moved towards a patient-centered approach to drug development. The National Cancer Moonshot, a task force led by Vice President Joseph Biden, includes this patient-centric strategy in its agenda: Seeking to facilitate collaborations with researchers, doctors, philanthropies, patients, patient advocates, and biotechnology and pharmaceutical companies to accelerate the early detection and treatment of cancer, its goal is a decade’s worth of advances in five years.

Read more here.